Biochemical characterization of antibody-based radioconjugates for SPECT/PET/CT imaging of prostate cancer. The monoclonal antibodies and their derivatives are produced in collaboration with several research groups in New York, Åbo and Malmö. These antibodies bind specifically to human kallikrein 2 (hK2), which are abundantly expressed in prostatic tissue. The purpose of this project is to target the hK2 protein with radiolabelled antibodies and/or antibody fragments in order to detect metastases and with suitable radioisotopes to treat tumours.

Eligibility/Entry Requirements

Basic and formal requirements for PhD studies in medical radiation physics. For this position, it is advantageous to have practical experiences in protein conjugation, separation techniques and radiochemistry, as well as practical experiences in immunoassays and cell studies.

Basis of Assessment

Those who hold an educational stipend or a doctoral student appointment must first be accepted for postgraduate studies. To be accepted, a student must be judged to have the competence necessary to complete a course of postgraduate studies.

Additional Information

A doctoral grant, SEK 15.500 per month, will be paid for a period of 18 months. After this period, the student will, after application, get a position as PhD student.
The doctoral grant is included in and supported by the FLÄK (The Research School in Pharmaceutical Science).

For further information please contact:
Sven-Erik Strand, PhD, professor
046-173116
Sven-Erik.Strand@med.lu.se

Labour union
OFR/S: Lena Thiman
046-222 7796
Lena.Thiman@med.lu.se

SACO: Andreas Lundin
046-222 9364
Andreas.Lundin@SACO.lu.se

Last Day of Applying; 2010-10-07

Application Deadline : 7 October 2010